Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Bruce E. Sands, Laurent Peyrin-Biroulet, Edward V. Loftus, Silvio Danese, Jean-Frederic Colombel, Murat Toruner, Laimas Jonaitis, Brihad Abhyankar, Jingjing Chen, Raquel Rogers, Richard A. Lirio, Jeffrey D. Bornstein, Stefan Schreiber, Marieke Pierik, VARSITY Study Group

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1215-1226
Number of pages12
JournalNew England Journal of Medicine
Volume381
Issue number13
DOIs
Publication statusPublished - 26 Sep 2019

Keywords

  • EFFICACY
  • THERAPY
  • DISEASE
  • SCORE

Cite this